Publications by authors named "Katia Kerdja"
Background: Triple negative breast cancers (TNBC) account for approximately 15% of all breast cancers and are associated with a shorter median survival mainly due to locally advanced tumor and high risk of metastasis. The current neoadjuvant treatment for TNBC consists of a regimen of immune checkpoint blocker and chemotherapy (chemo-ICB). Despite the frequent use of this combination for TNBC treatment, moderate results are observed and its clinical benefit in TNBC remains difficult to predict.
View Article and Find Full Text PDFArticle Synopsis
- Germ cell tumors and sex cord stromal tumors are rare ovarian cancers primarily affecting young women, generally treated with conservative surgery and chemotherapy (BEP), which may lead to long-term health issues.
- The GINECO-VIVROVAIRE study aims to evaluate chronic fatigue, quality of life, and long-term side effects of chemotherapy, especially concerning cardiovascular and pulmonary health in survivors.
- The study involves comparing 134 ovarian cancer survivors treated with surgery and chemotherapy to control groups, and further medical evaluations will be conducted on a subgroup to assess long-term effects and associated costs.